Tranexamic Acid is an antifibrinolytic agent and a synthetic lysine analog used clinically to prevent or reduce excessive bleeding by competitively inhibiting the activation of plasminogen to plasmin.… Read more













Tranexamic Acid is an antifibrinolytic agent and a synthetic lysine analog used clinically to prevent or reduce excessive bleeding by competitively inhibiting the activation of plasminogen to plasmin. This category features a comprehensive collection of Tranexamic Acid reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and synthetic analogs. Pharmaceutical laboratories utilize these materials for impurity profiling, stability testing, and rigorous analytical method validation to ensure regulatory compliance and therapeutic safety. To support precise quantification and accurate identification, this selection also includes stable isotope labelled compounds, such as deuterium and carbon-13 labelled variants, which serve as essential internal standards for mass spectrometry-based assays. By providing characterized standards for process-related compounds and synthetic intermediates, this catalogue supports quality control protocols throughout the pharmaceutical development lifecycle and the assessment of drug product purity under established guidelines.